Ensysce Biosciences, Inc. Banner Image

Ensysce Biosciences, Inc.

  • Ticker ENSC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Ensysce Biosciences, Inc. Logo Image
  • 11-50 Employees
  • Based in La Jolla, California
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses. Their approach is to look at drug delivery from a different view, using sophisticated chemistry to change the mode of activationMore rather than just modify a formulation. They combine anti-abuse and anti-overdose technology to effectively control the way a drug is turned on or turned off. This works by means of a unique 2-step verification mechanism for oral administration.
4.7 / 5.0 (150)

Ensysce Biosciences, Inc. reports have an aggregate usefulness score of 4.7 based on 150 reviews.

Ensysce Biosciences, Inc.

Most Recent Annual Report

Ensysce Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Ensysce Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!